Unshakable Confidence
Replacing the fear of “Am I doing this right?” with the certainty that you have the systems to build or scale your business safely. You'll operate from a place of purpose, not panic.
FDA Peptide Update: What Providers Need to Know Now
This free clinical guide breaks down the latest FDA peptide updates and the regulatory realities many providers are overlooking, so you can prescribe more responsibly, document with confidence, and protect both your patients and your license.
Download The Free Guide Now
This guide was born from the growing confusion around peptides and the providers trying to do the right thing without clear regulatory guidance. It isn’t academic theory. It’s the clinical awareness every provider needs when practicing in a rapidly evolving space.
- Danni Owens, FNP-BC
Just Imagine...
Clinical Clarity
Walking into every peptide consult understanding the regulatory landscape, documentation expectations, and clinical rationale behind your protocols — so your decisions are guided by structure, not guesswork.
Clinical Clarity
Understanding how regulatory updates impact peptide prescribing so you can structure protocols, document intentionally, and practice with confidence instead of uncertainty.
The Problem No One's
Talking About
Thousands of providers are adding peptide therapy to their practices as interest continues to grow.
But many are navigating it without clear regulatory guidance.
The truth is: prescribing peptides isn’t the same as understanding the clinical and compliance responsibilities behind them.
Prescribing peptides isn’t the same as understanding the clinical and compliance responsibilities that come with them.
Most peptide training focuses on protocols and trending compounds… but rarely addresses the regulatory awareness and clinical responsibility that determine whether providers are practicing safely.
In peptide-based practices, providers are navigating a rapidly changing landscape because critical regulatory and compliance considerations were never clearly explained.
This Guide Is For You If...
You’re currently prescribing peptides or considering adding them to your practice and want to understand the regulatory landscape.
You’ve seen the recent FDA updates and want a clear breakdown of what they actually mean for providers.
You want to ensure your documentation, informed consent, and prescribing decisions are structured and defensible.
You want to practice peptide therapy responsibly while protecting both your patients and your license.
You’re tired of sorting through conflicting information from social media, vendors, and online forums.
What You'll Discover Inside:
What the latest FDA peptide updates actually mean for providers — and why regulatory review doesn’t automatically mean a substance is banned.
The difference between FDA-approved drugs and compounded peptides, including how 503A vs. 503B compounding pharmacies impact prescribing decisions.
The documentation and informed consent elements providers must include when prescribing therapies that are not FDA-approved for specific indications.
A regulatory risk awareness checklist to help ensure your peptide prescribing, sourcing, and charting could withstand a board audit.
I Created This Because I've Watched Too Many Providers Struggle
I'll never forget the conversation I had with a provider who said to me, “I thought this was supposed to be straightforward.”
They had taken the trainings.
Followed the protocols.
Ordered from the pharmacy they were told was reputable.
But then the FDA announcements started coming out.
Suddenly there were questions everywhere.
Is this peptide still allowed?
What does this list actually mean?
Are we supposed to stop prescribing it?
That’s when I realized something important:
Most peptide education focuses on protocols and outcomes… but almost no one teaches providers how to navigate the regulatory realities behind them.
I created this guide because I’ve seen how quickly confusion spreads in fast-moving spaces like peptide therapy—and how easily providers can be left trying to sort through headlines, rumors, and vendor marketing to figure out what actually matters.
Providers deserve clear, responsible information so they can practice confidently while protecting both their patients and their licenses.
No provider should feel like they’re practicing in the dark when the regulatory landscape shifts.
— Danni Owens, FNP-BC
Danni Owens, FNP is a practicing Nurse Practitioner and founder of Slimming Grace Academy. After seeing the rapid rise of peptide therapy—and the confusion many providers face around regulation, safety, and documentation—she began creating provider education focused on responsible peptide prescribing. Her mission is to help clinicians understand the clinical and regulatory realities of emerging therapies so they can practice with confidence while protecting their patients and their licenses.
Stop Second-Guessing.
Start Practicing With Confidence.
Your clinical judgment is your most valuable asset. In the few minutes it takes to read this guide, you’ll gain the regulatory clarity that separates protocol-followers from providers who truly understand peptide therapy.
Don’t let another regulatory shift leave you guessing.
